Assessment of Kratom under the CSA Eight Factors and Scheduling Recommendation submitted to the DEA by Pinney & Associates 11-2016

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators, Journal Of The American Chemical Society: 6-6-16 Report

Pharmacokinetics of Mitragynine in Man: 12-21-14

Alkaloids Identified in Mitragyna Speciosa, Kratom: 10-8-2014

Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opiods from a Non-Opium Source:  2015

An Evidence-Based Systematic Review of Kratom: 6-3-2013

Total Synthesis of (-)-Mitragynine and Analogues:2012

Evaluation of Antioxidant and Antibacterial Activities of Aqueous, Methanolic and Alkaloid Extracts from Mitragyna Speciosa (Rubiaceae Family) Leaves: 2009

Computational Study on the Conformations of Mitragynine and Mitragynaline: 2010

Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth): 2008

Acute Toxicity Study of Standardized Mitragyna speciosa Korth Aqueous Extract in Sprague Dawley Rats:

Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput Assay:

Pharmacological Studies on 7-Hydroxymitragynine, Isolated from the Thai Herbal Medicine Mitragyna speciosa: Discovery of an Orally Active Opioid Analgesic:

In Vitro and in Vivo Effects of Three Different Mitragyna speciosa Korth Leaf Extracts on Phase II Drug Metabolizing Enzymes—Glutathione Transferases (GSTs):

The Neuromuscular Blockade Produced by Pure Alkaloid, Mitragynine and Methanol Extract of Kratom Leaves (Mitragyna speciosa Korth.):

Genes Induced by High Concentration of Salicylic Acid in Mitragyna Speciosa:


Take Action & Join the Conversation

Tell us your story Donate


Sign Up

Take Action & Join the Conversation